Cortisol
Cortisol is the central effector molecule of the HPA axis and the single most studied hormone of the stress response. In acute elevation, cortisol mobilizes glucose from liver glycogen stores, sharpens cognitive attention, suppresses non-essential functions (digestion, reproduction, immune deployment), and prepares the body to meet immediate demand. In chronic elevation — the hormonal signature of the resistance phase — cortisol sustains heightened function while producing cumulative damage: immune suppression that increases infection risk, cardiovascular remodeling that increases heart disease risk, hippocampal atrophy that impairs memory consolidation, and metabolic dysregulation that produces insulin resistance. The distinction between acute and chronic cortisol elevation is the distinction between a hormone that protects and a hormone that damages, and the same molecule serves both functions depending on duration.
In the AI Story
Cortisol was isolated in the 1930s by Edward Kendall and Philip Hench, who received the Nobel Prize in 1950 for their work on adrenal steroids. The hormone's role in stress response was established through Selye's framework and elaborated through subsequent decades of research on its receptors, feedback mechanisms, and tissue effects.
The distinction between cortisol's acute protective effects and its chronic damaging effects is foundational to contemporary stress medicine. Acute cortisol enables survival: the surge that accompanies genuine emergency mobilizes the resources the organism needs to respond. Chronic cortisol elevation — sustained for weeks or months without adequate trough periods — produces the damage Selye documented and McEwen specified.
Cortisol's diurnal rhythm provides a natural example of the intermittency the stress response requires. Healthy regulation produces a morning peak (the cortisol awakening response) that mobilizes the body for the day, followed by a gradual decline through afternoon and evening, reaching a nighttime trough that allows restoration. Disrupted sleep, continuous engagement, and chronic stress flatten this rhythm — producing a state of sustained moderate elevation without the troughs that permit recovery.
Measuring cortisol clinically typically involves sampling at multiple times of day to capture the rhythm, or measuring cortisol metabolites in hair to capture cumulative exposure over months. The diurnal slope — the difference between morning peak and evening trough — is often more diagnostically meaningful than any single measurement, and flattened slopes correlate with burnout, chronic disease, and accelerated aging.
Origin
Cortisol was isolated from adrenal cortex extracts in the 1930s by multiple research groups working simultaneously. Kendall at the Mayo Clinic and Reichstein in Switzerland independently characterized the compound, with Hench establishing its clinical significance through his work on rheumatoid arthritis.
Key Ideas
Dual function. The same molecule protects in acute surge and damages in chronic elevation — duration, not presence, determines effect.
Diurnal rhythm. Healthy regulation produces a morning peak and evening trough; flattened rhythms indicate chronic stress.
Immune suppression. Cortisol's anti-inflammatory effects, therapeutic in short bursts, produce the immunocompromise of the resistance phase.
Hippocampal effects. Chronic cortisol elevation produces measurable atrophy of memory-consolidation structures — the mechanism through which sustained stress impairs learning.
Receptor desensitization. Chronic elevation produces glucocorticoid resistance, the molecular basis of the feedback-loop disruption that sustains the resistance phase beyond its adaptive window.
Appears in the Orange Pill Cycle
Further reading
- Sapolsky, Robert M., L. Michael Romero, and Allan U. Munck. 'How Do Glucocorticoids Influence Stress Responses?' Endocrine Reviews 21, no. 1 (2000): 55–89.
- Miller, Gregory E., Edith Chen, and Eric S. Zhou. 'If It Goes Up, Must It Come Down?' Psychological Bulletin 133, no. 1 (2007): 25–45.
- Adam, Emma K., and Meena Kumari. 'Assessing Salivary Cortisol in Large-Scale, Epidemiological Research.' Psychoneuroendocrinology 34, no. 10 (2009): 1423–1436.
- McEwen, Bruce S. 'Glucocorticoids, Depression, and Mood Disorders.' Metabolism 54, no. 5 Suppl 1 (2005): 20–23.